Cargando…

Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study

The Movement Disorder Society Task Force (MDS-TF) has proposed diagnostic criteria for mild cognitive impairment in Parkinson’s disease (PD-MCI). We hypothesized that the risk of dementia (PDD) varies across the different cutoff schemes allowed. A longitudinal study followed 121 non-demented PD pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wood, Kyla-Louise, Myall, Daniel J, Livingston, Leslie, Melzer, Tracy R, Pitcher, Toni L, MacAskill, Michael R, Geurtsen, Gert J, Anderson, Tim J, Dalrymple-Alford, John C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516585/
https://www.ncbi.nlm.nih.gov/pubmed/28725690
http://dx.doi.org/10.1038/npjparkd.2015.27
_version_ 1783251186933039104
author Wood, Kyla-Louise
Myall, Daniel J
Livingston, Leslie
Melzer, Tracy R
Pitcher, Toni L
MacAskill, Michael R
Geurtsen, Gert J
Anderson, Tim J
Dalrymple-Alford, John C
author_facet Wood, Kyla-Louise
Myall, Daniel J
Livingston, Leslie
Melzer, Tracy R
Pitcher, Toni L
MacAskill, Michael R
Geurtsen, Gert J
Anderson, Tim J
Dalrymple-Alford, John C
author_sort Wood, Kyla-Louise
collection PubMed
description The Movement Disorder Society Task Force (MDS-TF) has proposed diagnostic criteria for mild cognitive impairment in Parkinson’s disease (PD-MCI). We hypothesized that the risk of dementia (PDD) varies across the different cutoff schemes allowed. A longitudinal study followed 121 non-demented PD patients for up to 4.5 years. In Part One, unique groups of patients were identified as PD-MCI at baseline using the MDS-TF requirement of two impaired cognitive test scores, with both scores classified as impaired at either (i) 2 s.d., (ii) 1.5 s.d. or (iii) 1 s.d. below normative data; relative risk (RR) of PDD was assessed at each criterion. In Part Two, the whole sample was reassessed and (i) RR of PDD determined when two impairments at 1.5 s.d. existed within a single cognitive domain, followed by (ii) RR of PDD in the unique group whose two impairments at 1.5 s.d. did not exist within a single domain (i.e., only across two domains). Twenty-one percent of patients converted to PDD. Part One showed that the 1.5 s.d. criterion at baseline is optimal to maximize progression to PDD over 4 years. Part Two, however, showed that the 1.5 s.d. cutoff produced a high RR of PDD only when two impairments were identified within a single cognitive domain (7.2, 95% confidence interval (CI)=3.4–16.6, P<0.0001; 51% converted). The RR when the 1.5 s.d. impairments occurred only across two different domains, was nonsignificant (1.7, CI=0.5–7.4, P=0.13; 11% converted) and similar to using a 1 s.d. criterion (1.9, CI=0.3–4.3, P=0.13; 8% converted). If the intent of a PD-MCI diagnosis is to detect increased risk of PDD in the next 4 years, optimal criteria should identify at least two impairments at 1.5 s.d. within a single cognitive domain.
format Online
Article
Text
id pubmed-5516585
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-55165852017-07-19 Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study Wood, Kyla-Louise Myall, Daniel J Livingston, Leslie Melzer, Tracy R Pitcher, Toni L MacAskill, Michael R Geurtsen, Gert J Anderson, Tim J Dalrymple-Alford, John C NPJ Parkinsons Dis Article The Movement Disorder Society Task Force (MDS-TF) has proposed diagnostic criteria for mild cognitive impairment in Parkinson’s disease (PD-MCI). We hypothesized that the risk of dementia (PDD) varies across the different cutoff schemes allowed. A longitudinal study followed 121 non-demented PD patients for up to 4.5 years. In Part One, unique groups of patients were identified as PD-MCI at baseline using the MDS-TF requirement of two impaired cognitive test scores, with both scores classified as impaired at either (i) 2 s.d., (ii) 1.5 s.d. or (iii) 1 s.d. below normative data; relative risk (RR) of PDD was assessed at each criterion. In Part Two, the whole sample was reassessed and (i) RR of PDD determined when two impairments at 1.5 s.d. existed within a single cognitive domain, followed by (ii) RR of PDD in the unique group whose two impairments at 1.5 s.d. did not exist within a single domain (i.e., only across two domains). Twenty-one percent of patients converted to PDD. Part One showed that the 1.5 s.d. criterion at baseline is optimal to maximize progression to PDD over 4 years. Part Two, however, showed that the 1.5 s.d. cutoff produced a high RR of PDD only when two impairments were identified within a single cognitive domain (7.2, 95% confidence interval (CI)=3.4–16.6, P<0.0001; 51% converted). The RR when the 1.5 s.d. impairments occurred only across two different domains, was nonsignificant (1.7, CI=0.5–7.4, P=0.13; 11% converted) and similar to using a 1 s.d. criterion (1.9, CI=0.3–4.3, P=0.13; 8% converted). If the intent of a PD-MCI diagnosis is to detect increased risk of PDD in the next 4 years, optimal criteria should identify at least two impairments at 1.5 s.d. within a single cognitive domain. Nature Publishing Group 2016-01-14 /pmc/articles/PMC5516585/ /pubmed/28725690 http://dx.doi.org/10.1038/npjparkd.2015.27 Text en Copyright © 2016 Parkinson's Disease Foundation/Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Wood, Kyla-Louise
Myall, Daniel J
Livingston, Leslie
Melzer, Tracy R
Pitcher, Toni L
MacAskill, Michael R
Geurtsen, Gert J
Anderson, Tim J
Dalrymple-Alford, John C
Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study
title Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study
title_full Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study
title_fullStr Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study
title_full_unstemmed Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study
title_short Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study
title_sort different pd-mci criteria and risk of dementia in parkinson’s disease: 4-year longitudinal study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516585/
https://www.ncbi.nlm.nih.gov/pubmed/28725690
http://dx.doi.org/10.1038/npjparkd.2015.27
work_keys_str_mv AT woodkylalouise differentpdmcicriteriaandriskofdementiainparkinsonsdisease4yearlongitudinalstudy
AT myalldanielj differentpdmcicriteriaandriskofdementiainparkinsonsdisease4yearlongitudinalstudy
AT livingstonleslie differentpdmcicriteriaandriskofdementiainparkinsonsdisease4yearlongitudinalstudy
AT melzertracyr differentpdmcicriteriaandriskofdementiainparkinsonsdisease4yearlongitudinalstudy
AT pitchertonil differentpdmcicriteriaandriskofdementiainparkinsonsdisease4yearlongitudinalstudy
AT macaskillmichaelr differentpdmcicriteriaandriskofdementiainparkinsonsdisease4yearlongitudinalstudy
AT geurtsengertj differentpdmcicriteriaandriskofdementiainparkinsonsdisease4yearlongitudinalstudy
AT andersontimj differentpdmcicriteriaandriskofdementiainparkinsonsdisease4yearlongitudinalstudy
AT dalrymplealfordjohnc differentpdmcicriteriaandriskofdementiainparkinsonsdisease4yearlongitudinalstudy